GlassScriptPhysician profile
Vicky T Baugher
NPI 1871800409
$2,421.66
in general payments reported to CMS, 2019-2025
19 companies · $623 in 2025
The $623 reported for 2025 was more than what 77% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $514 · 2022: $388 · 2023: $357 · 2024: $539 · 2025: $623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,519.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $744.40 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $382.25 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $246.77 | 2021-2025 | Mounjaro, Zepbound, Emgality |
| Abbvie INC. | $216.71 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $197.26 | 2021-2025 | Jardiance |
| Glaxosmithkline, LLC. | $146.20 | 2021-2024 | Trelegy Ellipta |
| Exact Sciences Corporation | $96.67 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $95.11 | 2023-2025 | |
| Nestle Healthcare Nutrition INC. | $47.40 | 2021 | |
| Axsome Therapeutics, INC. | $44.28 | 2024-2025 | Sunosi |
| Alkermes, INC. | $36.23 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $35.61 | 2022 | |
| Astellas Pharma US INC | $31.14 | 2025 | Veozah |
| Antares Pharma, INC. | $24.48 | 2024 | Xyosted |
| Abbott Laboratories | $18.04 | 2023 | Freestyle Libre 3 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $16.41 | 2025 | Nuzyra |
| Acella Pharmaceuticals, LLC | $15.73 | 2025 | NP Thyroid 60 |
| Biohaven Pharmaceuticals, INC. | $13.98 | 2021 | |
| Merck Sharp & Dohme LLC | $12.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vicky Baugher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.